Drug Discovery
-
apceth, Indivumed to develop biomarker platform for targeted cellular therapies
apceth and Indivumed have entered into a partnership for the development of a predominantly tissue-based biomarker strategy for the treatment of solid cancers with cellular and / or gene therapeutics.
Drug Discovery | 27 March 2012
-
ICON to support study evaluating variability in insulin secretory parameters
Selected by Biomarkers Consortium of the FNIH.
Drug Discovery | 21 October 2011
-
Agilent Technologies and University of Technology, Sydney, open joint nuclear magnet resonance facility
NMR facility will be home to cutting-edge technology to support a range of UTS staff and student research projects.
Drug Discovery | 20 October 2011
-
Thermo Fisher Scientific screening library advances drug discovery research
20,000-molecule Maybridge collection will help identify compound candidates to treat a wide range of diseases.
Drug Discovery | 18 October 2011
-
Progenra and Ono Pharmaceutical enter into research collaboration
Progenra will collaborate with Ono to conduct assay development and high throughput screening by using Progenra’s proprietary technology on multiple targets in the ubiquitin pathway.
Drug Discovery | 12 October 2011
-
Agilent Technologies supports research at the Broad Institute
Developing proteomics technology to detect disease biomarkers.
Drug Discovery | 12 October 2011
-
Launch of BioLynx provides a boost for the international malaria research community
New NUS spin-off company launches at TechVenture 2011.
Drug Discovery | 12 October 2011
-
Bi-axial bioreactor set to revolutionise pre-clinical trials in the field of regenerative medicine.
Technology jointly developed by National University of Singapore and Singapore Polytechnic, and commercialised by local start-up company.
Drug Discovery | 10 October 2011
-
India generics companies lead pharmaceutical innovation in Asia Pacific
Thomson Reuters Asia Pacific R&D Factbook details significant increases in innovation investment and development of novel drug pipelines.
Drug Discovery | 30 September 2011
-
AB SCIEX QTRAP technology assists Yale researchers to engineer a phosphoprotein
Synthetic biology-based approach successfully re-engineers protein-making mechanisms in bacteria.
Drug Discovery | 29 September 2011
